• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A brief overview of clinical significance of novel Notch2 regulators.新型Notch2调节因子的临床意义简要概述。
Mol Cell Oncol. 2020 Jun 30;7(5):1776084. doi: 10.1080/23723556.2020.1776084. eCollection 2020.
2
Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.靶向 Notch 信号通路的 Notch2/Notch3 拮抗剂(tarextumab)可抑制肿瘤生长并降低肿瘤起始细胞频率。
Clin Cancer Res. 2015 May 1;21(9):2084-95. doi: 10.1158/1078-0432.CCR-14-2808.
3
Effect of lenalidomide on the human gastric cancer cell line SGC7901/vincristine Notch signaling.来那度胺对人胃癌细胞系SGC7901/长春新碱Notch信号通路的影响。
J Cancer Res Ther. 2018;14(Supplement):S237-S242. doi: 10.4103/0973-1482.183181.
4
MicroRNA-34b-5p inhibits proliferation, stemness, migration and invasion of retinoblastoma cells via Notch signaling.微小RNA-34b-5p通过Notch信号通路抑制视网膜母细胞瘤细胞的增殖、干性、迁移和侵袭。
Exp Ther Med. 2021 Mar;21(3):255. doi: 10.3892/etm.2021.9686. Epub 2021 Jan 25.
5
Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.Notch1 和 Notch2 在 Kras(G12D)驱动的小鼠非小细胞肺癌模型中的拮抗作用。
Oncogene. 2015 Jan 29;34(5):578-88. doi: 10.1038/onc.2013.592. Epub 2014 Feb 10.
6
The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.Notch2信号通路与miR-23b在调控胃癌发生中的相互调节环路
Oncotarget. 2015 Jul 20;6(20):18012-26. doi: 10.18632/oncotarget.4000.
7
Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.胃癌中 Notch1 和 Notch2 的差异表达和 Notch 信号通路的频繁激活。
Arch Pathol Lab Med. 2011 Apr;135(4):451-8. doi: 10.5858/2009-0665-OA.1.
8
Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.Notch1和Notch2受体调节小鼠和人类胃窦上皮细胞的稳态。
Gut. 2017 Jun;66(6):1001-1011. doi: 10.1136/gutjnl-2015-310811. Epub 2016 Mar 1.
9
Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.并非所有 NOTCH 都相同:NOTCH2 在膀胱癌中的致癌作用及其对靶向治疗的意义。
Clin Cancer Res. 2016 Jun 15;22(12):2981-92. doi: 10.1158/1078-0432.CCR-15-2360. Epub 2016 Jan 14.
10
Inflammatory cytokines induce NOTCH signaling in nucleus pulposus cells: implications in intervertebral disc degeneration.炎性细胞因子诱导髓核细胞中的 NOTCH 信号通路:在椎间盘退变中的意义。
J Biol Chem. 2013 Jun 7;288(23):16761-16774. doi: 10.1074/jbc.M112.446633. Epub 2013 Apr 15.

引用本文的文献

1
Serum proteomic approach to identifying differentially expressed proteins in effusive feline infectious peritonitis.采用血清蛋白质组学方法鉴定渗出性猫传染性腹膜炎中差异表达的蛋白质。
Sci Rep. 2025 May 29;15(1):18899. doi: 10.1038/s41598-025-03108-2.
2
Could , , , , and Be Useful Tools as a Target Therapy for Uterine Leiomyosarcoma?……以及……能否作为子宫平滑肌肉瘤的靶向治疗有用工具? (你提供的原文中部分内容缺失,我只能按现有内容翻译)
Biomedicines. 2025 Feb 23;13(3):560. doi: 10.3390/biomedicines13030560.
3
Regulatory effect of traditional Chinese medicines on signaling pathways of process from chronic atrophic gastritis to gastric cancer.中药对慢性萎缩性胃炎向胃癌转变过程中信号通路的调控作用
Chin Herb Med. 2021 Dec 21;14(1):5-19. doi: 10.1016/j.chmed.2021.10.008. eCollection 2022 Jan.

本文引用的文献

1
Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.非编码 RNA 和 RNA 修饰物在癌症治疗耐药中的作用。
Mol Cancer. 2020 Mar 2;19(1):47. doi: 10.1186/s12943-020-01171-z.
2
The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target.致癌性Notch2信号通路在癌症中的作用:一个新的治疗靶点。
Am J Cancer Res. 2019 May 1;9(5):837-854. eCollection 2019.
3
miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.微小RNA-758-3p通过靶向Notch2抑制人膀胱癌细胞的增殖、迁移和侵袭。
Exp Ther Med. 2019 May;17(5):4273-4278. doi: 10.3892/etm.2019.7400. Epub 2019 Mar 18.
4
Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.长链非编码 RNA(lncRNA)MIR22HG 通过抑制 NOTCH2 信号通路抑制胃癌进展。
Med Sci Monit. 2019 Jan 23;25:656-665. doi: 10.12659/MSM.912813.
5
N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.N-乙酰半胱氨酸通过抑制 Notch2 信号通路降低神经胶质瘤细胞的恶性特征。
J Exp Clin Cancer Res. 2019 Jan 3;38(1):2. doi: 10.1186/s13046-018-1016-8.
6
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors.一项评估 TarExtumab(OMP-59R5)在实体瘤患者中的 1 期剂量递增和扩展研究。
Invest New Drugs. 2019 Aug;37(4):722-730. doi: 10.1007/s10637-018-0714-6. Epub 2018 Dec 28.
7
MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2.MiR-1-5p在胆囊癌中表达下调,并通过靶向Notch2抑制细胞增殖、迁移和侵袭。
Pathol Res Pract. 2019 Jan;215(1):200-208. doi: 10.1016/j.prp.2018.10.013. Epub 2018 Oct 22.
8
miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.miR-181b/Notch2 通过调节 NSCLC 中的肿瘤干细胞样特性来克服化疗耐药性。
Stem Cell Res Ther. 2018 Nov 23;9(1):327. doi: 10.1186/s13287-018-1072-1.
9
MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.MicroRNA-133a 通过靶向早老素 1 抑制胃癌细胞的生长、迁移和上皮-间充质转化过程。
J Cell Biochem. 2019 Jan;120(1):470-480. doi: 10.1002/jcb.27403. Epub 2018 Aug 30.
10
Advances in antibody therapeutics targeting small-cell lung cancer.靶向小细胞肺癌的抗体疗法进展
Adv Clin Exp Med. 2018 Sep;27(9):1317-1323. doi: 10.17219/acem/70159.

新型Notch2调节因子的临床意义简要概述。

A brief overview of clinical significance of novel Notch2 regulators.

作者信息

Pancewicz Joanna

机构信息

Department of Histology and Embryology, Medical University of Bialystok, Bialystok, Poland.

出版信息

Mol Cell Oncol. 2020 Jun 30;7(5):1776084. doi: 10.1080/23723556.2020.1776084. eCollection 2020.

DOI:10.1080/23723556.2020.1776084
PMID:32944632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7480808/
Abstract

The Notch pathway is an essential signaling system allowing neighboring cells to communicate and accomplish their proper developmental role in physiological condition. Nevertheless, there are many controversies conferring its function in pathological condition, particularly in cancer. It has been discovered that epigenetic regulation, posttranslational modifications, gene overexpression, and mutations may lead to the dysregulation of the Notch pathway. Additionally, Notch-mediated signaling can support tumor-suppressing mechanisms in certain types of cancer or may have oncogenic functions in others. Notch2 is one of the receptors commonly expressed in a variety of cancer cells, including gastric, hematological, and lung cancer. Moreover, it can be dysregulated in other diseases. In efforts to explain the role of Notch2 in the pathogenesis of cancer, recent studies indicated an association between this receptor and dysregulation of miRNAs, tumor-associated stromal cell, and modulation in tumor cells. Consequently, Notch2 function in the carcinogenesis process is unquestionable, whereas information according to the effect of its inhibition in tumor is still obscure. Hence, the aim of our study was to evaluate the current state of knowledge conferring Notch2 inhibition, with a particular focus on its role in cancer.

摘要

Notch信号通路是一种重要的信号系统,可使相邻细胞进行通讯,并在生理状态下发挥其正常的发育作用。然而,关于其在病理状态下,尤其是在癌症中的功能,仍存在许多争议。现已发现,表观遗传调控、翻译后修饰、基因过表达和突变可能导致Notch信号通路失调。此外,Notch介导的信号传导在某些类型的癌症中可能支持肿瘤抑制机制,而在其他癌症中可能具有致癌功能。Notch2是一种在多种癌细胞中普遍表达的受体,包括胃癌、血液系统癌症和肺癌。此外,它在其他疾病中也可能失调。为了解释Notch2在癌症发病机制中的作用,最近的研究表明该受体与miRNA失调、肿瘤相关基质细胞以及肿瘤细胞中的调节有关。因此,Notch2在致癌过程中的作用是毋庸置疑的,而关于其抑制对肿瘤影响的信息仍不清楚。因此,我们研究的目的是评估目前关于Notch2抑制的知识状态,特别关注其在癌症中的作用。